Expert feedback highlighted missing information about dosages and administration routes in certain responses (a misassociation where the model incorrectly linked insulin use to prediabetes despite a type 2 diabetes diagnosis) and instances where rare side effects were inaccurately reported as common. The gene discussed is INS; the disease is prediabetes syndrome.